Körber Medipak Systems Opens New Location in Sao Paulo
News May 22, 2015
Körber Medipak Systems has opened a new location in Sao Paulo. Due to growing populations in Latin America, with current figures at over 600 million people, the pharmaceutical industry is recording strong growth in the region, particularly in Brazil. The services of the new location are meeting the increasing need for solutions for the pharmaceutical and biotech industry in Latin America, from Mexico to Argentina.
As a market leader in pharmaceutical solutions, Körber Medipak Systems, with its strong customer base and over 100 installations, is highly committed to this region and has an excellent reputation. The investment in a new location for Latin America is the logical consequence of this.
Located in Sao Paulo a well-trained and highly motivated team serves customers in Latin America. Customer can expect the complete portfolio of solutions and services to be offered. Besides the two managing directors, there are IT consultants from Werum IT Solutions, as well as sales and project managers for the inspection and packaging technology business, all of whom are based directly in situ. Specially trained service technicians for the installation and maintenance of the lines complete the team, which is set to grow further over the coming weeks and months.
Until now the regional and multinational customers of the Medipak Systems companies have been supported from bases in other countries. Now they can benefit from the advantages of having local experts with an international network. Borja Guerra, Managing Director of Körber Medipak América Latina: “Personal contact with our customer has proven to be the key to success in every country in which I have worked so far. With our office in Brazil, we are now able to give our customers even better support with a bigger team right on spot.”
Körber Medipak Systems América Latina is being expanded continuously. In future, it will employ more than 20 people. There are also plans for the manufacturing and warehousing of spare and format parts. Customers will profit from direct support by local experts and shorter reaction times.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE